According to the Tianyancha App, Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd. recently underwent business changes, and the registered capital increased from 220 million yuan to about 490 million yuan, an increase of about 121%. The company was founded in September 2006, and its legal representative is Peng Shaoping. Its business scope includes pharmaceutical production, drug contract production, pharmaceutical wholesale, etc., and is jointly owned by Fosun Wanbang Pharmaceutical Group Co., Ltd., Shanghai Fosun Pharmaceutical Industry Development Co., Ltd., and FOSUN INDUSTRIAL CO., LIMITED, a subsidiary of Fosun Pharmaceutical.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.